Nexentis Technologies (NXTS) Shares Outstanding (Diluted) (2022 - 2026)
Nexentis Technologies (NXTS) reported Weighted Average Shares Outstanding (Diluted) of 816,136 for Q2 2026, down 77.6% from 3.65 million a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Nexentis Technologies posted Weighted Average Shares Outstanding (Diluted) of 184,036, down 78.0% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has a three-year compound annual growth rate of 34.6% (FY2022 to FY2025).
- By year, Weighted Average Shares Outstanding (Diluted) came in at 835,176 in FY2024 (+386.9%), 171,515 in FY2023 (+127.1%) and 75,539 in FY2022.
- Five-year quarterly Weighted Average Shares Outstanding (Diluted) spans a low of 75,539 in Q4 2022 and a high of 3.65 million in Q2 2025.
- Year over year, Weighted Average Shares Outstanding (Diluted) gained in four of the last seven quarters, with growth averaging 255.3%.
- The high point for year-over-year Weighted Average Shares Outstanding (Diluted) in five years was Q1 2025 (growth of 652.8%); the low point was Q3 2025 (a decline of 83.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Nexentis Technologies | 2.04 Mn | -23.39 Mn | - | 816,136.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 816,136.00 |
| Dec 31, 2025 | 184,036.00 |
| Sep 30, 2025 | 138,212.00 |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 3.18 Mn |
| Dec 31, 2024 | 835,176.00 |
| Sep 30, 2024 | 831,470.00 |
| Jun 30, 2024 | 486,983.00 |
| Mar 31, 2024 | 422,952.00 |
| Dec 31, 2023 | 171,515.00 |
| Sep 30, 2023 | 190,153.00 |
| Jun 30, 2023 | 998,007.00 |
| Mar 31, 2023 | 99,418.00 |
| Dec 31, 2022 | 75,539.00 |
| Sep 30, 2022 | 79,690.00 |
| Jun 30, 2022 | 408,937.00 |
API Access
Nexentis Technologies Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();